Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025

The Market Herald

Yesterday

The ASX has been down 1.5% at 7,739 points this morning.

There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.

Staples and Health Care are the only sectors in positive territory so far.

In company news, Mesoblast (ASX:MSB) has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.

Orthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.

And, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.

More market news

Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”

Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst

Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2524478612"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2524478612\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2524478612?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-04 09:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524478612","market":"us","top_or_hot":-1,"title":"Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025","media":"The Market Herald","content":"<html><body><div>\n<p>The ASX has been down 1.5% at 7,739 points this morning.</p>\n<p>There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.</p>\n<p>Staples and Health Care are the only sectors in positive territory so far.</p>\n<p>In company news, Mesoblast (ASX:MSB) has been among the most watched on <em>HotCopper </em>forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.</p>\n<p>Orthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.</p>\n<p>And, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.</p>\n<figure><div>\n<div></div>\n</div></figure>\n<p><strong><em>More market news</em></strong></p>\n<p><strong><em>Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”</em></strong></p>\n<p><strong><em>Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst</em></strong></p>\n<p><strong>Join the discussion:</strong> See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.</p>\n<p><em>The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click</em> <em>here</em>.</p>\n</div></body></html>","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFriday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-04 09:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketonline.com.au/fridays-hotcopper-trends-mesoblast-dodges-tariffs-orthocells-fda-tick-april-4-2025-2025-04-04/><strong>The Market Herald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The ASX has been down 1.5% at 7,739 points this morning.\nThere’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.\nStaples and Health Care are ...</p>\n\n<a href=\"https://themarketonline.com.au/fridays-hotcopper-trends-mesoblast-dodges-tariffs-orthocells-fda-tick-april-4-2025-2025-04-04/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7104","symbol_name":"黄金","start_time":0,"source_url":"https://themarketonline.com.au/fridays-hotcopper-trends-mesoblast-dodges-tariffs-orthocells-fda-tick-april-4-2025-2025-04-04/","article_id":"2524478612","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524478612","pubTimestamp":1743731820,"columns":[],"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"The ASX has been down 1.5% at 7,739 points this morning.There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.Staples and Health Care are the only sectors in positive territory so far.In company news, Mesoblast  has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.Orthocell  has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.And, finally, Bellevue Gold  has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”。The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research a","collect":0,"end_time":0,"defaultTopTitle":"themarketonline.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7104":"黄金","BK7501":"新冠治疗股","BK7508":"医药生物股","BK4139":"生物科技","BGL.AU":"BELLEVUE GOLD LTD","MESO":"Mesoblast Limited","BK7067":"生物科技","OCC.AU":"ORTHOCELL LTD","MSB.AU":"MESOBLAST LTD"},"translate_title":"周五热门铜趋势：Mesoblast逃避关税，Orthocell的FDA将于2025年4月4日公布","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BGL.AU":1,"MESO":1,"MSB.AU":1,"OCC.AU":1},"content_text":"The ASX has been down 1.5% at 7,739 points this morning.\nThere’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.\nStaples and Health Care are the only sectors in positive territory so far.\nIn company news, Mesoblast (ASX:MSB) has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.\nOrthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.\nAnd, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.\n\n\n\nMore market news\nLevy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”\nMeet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst\nJoin the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.\nThe material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}